Our main focus: Common diseases such as asthma, allergies and chronic obstructive pulmonary disease (COPD), as well as infection-related inflammation of the lungs, in particular tuberculosis (TB).
02.03.2026
Dr. Bianca Schneider, Leiterin der Forschungsgruppe "Wirtsdeterminanten bei Lungeninfektionen" am Forschungszentrum Borstel, Leibniz Lungenzentrum erklärt in der aktuellen Folge "Forschung aktuell" vom #Deutschlandfunk, warum Männer häufiger an #Tuberkulose erkranken als Frauen und wie man ihre Forschungsergebnisse nutzen kann, um die Therapie in Zukunft zu verbessern. Und das nicht nur bei der Tuberkulose, sondern auch bei anderen Erregern:
26.02.2026
Double reason to celebrate: Shortly after receiving the Oskar Medical Award, the internationally renowned tuberculosis expert has now also been honored with the DZIF Prize for Translational Infection Research 2025. At the annual conference of the German Center for Infection Research in Bonn, he was recognized for his outstanding contributions to the prevention, diagnosis, and treatment of tuberculosis, particularly drug-resistant tuberculosis.
04.02.2026
Prof. Christoph Lange, Medical Director of the Research Center Borstel, Leibniz Lung Center, has been awarded the 2025 Oskar Medical Prize by the Oskar-Helene-Heim Foundation. The prize, worth €50,000, is one of the most highly endowed medical prizes in Germany.